Low T Center Comments on the Pending AndroGel Lawsuits Regarding the Safety of Testosterone Replacement

February 13, 2014 (Southlake, Texas) - A number of people have asked how the recent FDA inquiries into testosterone therapy, and the related lawsuits brought by AndroGel patients, effect Low T Center. "The answer is that they don't really relate to the medicine we practice at Low T Center," says Dr. William Reilly, M.D., Executive Director of the physician practice group treating patients in Low T Centers. "We are excited about the FDA's inquiry into alternative testosterone delivery models," says Reilly.